Some properties of blood stored in anticoagulant CPDA-1 solution. A brief summary

Approval of the new anticoagulant preservative, CPDA-1, was based in part on data from human clinical trials of CPDA-1 performed by six cooperating laboratories and two blood bag manufacturers. Biochemical and red blood cell survival properties of 123 units of blood stored for 28 to 35 days in CPDA-...

Full description

Saved in:
Bibliographic Details
Published inTransfusion (Philadelphia, Pa.) Vol. 21; no. 2; p. 135
Main Authors Moore, G L, Peck, C C, Sohmer, P R, Zuck, T F
Format Journal Article
LanguageEnglish
Published United States 01.01.1981
Subjects
Adenine - pharmacology
Anticoagulants
Blood
Blood Preservation
Cell Survival
Citrates - pharmacology
Erythrocytes - physiology
Glucose - pharmacology
Hematocrit
Humans
Phosphates - pharmacology
Solutions
Online AccessGet more information

Cover

More Information
Summary:Approval of the new anticoagulant preservative, CPDA-1, was based in part on data from human clinical trials of CPDA-1 performed by six cooperating laboratories and two blood bag manufacturers. Biochemical and red blood cell survival properties of 123 units of blood stored for 28 to 35 days in CPDA-1 (as reported by cooperating laboratories) are briefly summarized.
ISSN:0041-1132
DOI:10.1046/j.1537-2995.1981.21281178147.x